These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 23066085)
1. 15-Lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cells. Hu Y; Sun H; O'Flaherty JT; Edwards IJ Carcinogenesis; 2013 Jan; 34(1):176-82. PubMed ID: 23066085 [TBL] [Abstract][Full Text] [Related]
2. Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer. Hu Y; Sun H; Owens RT; Gu Z; Wu J; Chen YQ; O'Flaherty JT; Edwards IJ Neoplasia; 2010 Oct; 12(10):826-36. PubMed ID: 20927321 [TBL] [Abstract][Full Text] [Related]
3. 15-lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survival. O'Flaherty JT; Hu Y; Wooten RE; Horita DA; Samuel MP; Thomas MJ; Sun H; Edwards IJ PLoS One; 2012; 7(9):e45480. PubMed ID: 23029040 [TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway. Sun H; Hu Y; Gu Z; Owens RT; Chen YQ; Edwards IJ Carcinogenesis; 2011 Oct; 32(10):1518-24. PubMed ID: 21771724 [TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of the Maresin Intermediate, 13S,14S-Epoxy-DHA, by Human 15-Lipoxygenase and 12-Lipoxygenase and Its Regulation through Negative Allosteric Modulators. Freedman C; Tran A; Tourdot BE; Kalyanaraman C; Perry S; Holinstat M; Jacobson MP; Holman TR Biochemistry; 2020 May; 59(19):1832-1844. PubMed ID: 32324389 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon. Sarveswaran S; Thamilselvan V; Brodie C; Ghosh J Biochim Biophys Acta; 2011 Dec; 1813(12):2108-17. PubMed ID: 21824498 [TBL] [Abstract][Full Text] [Related]
7. Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate. Alteration in peroxisome proliferator-activated receptor gamma. Hsi LC; Wilson LC; Eling TE J Biol Chem; 2002 Oct; 277(43):40549-56. PubMed ID: 12189136 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer. Tang Y; Wang MT; Chen Y; Yang D; Che M; Honn KV; Akers GD; Johnson SR; Nie D Int J Cancer; 2009 Apr; 124(7):1545-51. PubMed ID: 19089921 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. Pidgeon GP; Kandouz M; Meram A; Honn KV Cancer Res; 2002 May; 62(9):2721-7. PubMed ID: 11980674 [TBL] [Abstract][Full Text] [Related]
10. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818 [TBL] [Abstract][Full Text] [Related]
11. Investigating the Anti-tumor and Apoptosis-inducing Effects of Coumarin Derivatives as Potent 15-Lipoxygenase Inhibitors on PC-3 Prostate Cancer Cells. Maleki F; Sadeghian H; Bahrami AR; Goftari SN; Matin MM Anticancer Agents Med Chem; 2023; 23(15):1722-1730. PubMed ID: 37171011 [TBL] [Abstract][Full Text] [Related]
12. Fatty acid oxidation and signaling in apoptosis. Tang DG; La E; Kern J; Kehrer JP Biol Chem; 2002; 383(3-4):425-42. PubMed ID: 12033433 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells. Sarveswaran S; Chakraborty D; Chitale D; Sears R; Ghosh J J Biol Chem; 2015 Feb; 290(8):4994-5006. PubMed ID: 25540201 [TBL] [Abstract][Full Text] [Related]
14. 15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5. Perry SC; Kalyanaraman C; Tourdot BE; Conrad WS; Akinkugbe O; Freedman JC; Holinstat M; Jacobson MP; Holman TR J Lipid Res; 2020 Jul; 61(7):1087-1103. PubMed ID: 32404334 [TBL] [Abstract][Full Text] [Related]
15. Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase. Moretti RM; Montagnani Marelli M; Sala A; Motta M; Limonta P Int J Cancer; 2004 Oct; 112(1):87-93. PubMed ID: 15305379 [TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells. Sun H; Berquin IM; Owens RT; O'Flaherty JT; Edwards IJ Cancer Res; 2008 Apr; 68(8):2912-9. PubMed ID: 18413760 [TBL] [Abstract][Full Text] [Related]
17. FFAR1-and FFAR4-dependent activation of Hippo pathway mediates DHA-induced apoptosis of androgen-independent prostate cancer cells. Wang J; Hong Y; Shao S; Zhang K; Hong W Biochem Biophys Res Commun; 2018 Nov; 506(3):590-596. PubMed ID: 30366669 [TBL] [Abstract][Full Text] [Related]
18. Involvement of apoptotic pathways in docosahexaenoic acid-induced benefit in prostate cancer: Pathway-focused gene expression analysis using RT Sun Y; Jia X; Hou L; Liu X; Gao Q Lipids Health Dis; 2017 Mar; 16(1):59. PubMed ID: 28330470 [TBL] [Abstract][Full Text] [Related]
19. Analysis of 12/15-lipoxygenase metabolism of EPA and DHA with special attention to authentication of docosatrienes. Jin J; Boeglin WE; Brash AR J Lipid Res; 2021; 62():100088. PubMed ID: 34022182 [TBL] [Abstract][Full Text] [Related]
20. Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals. Liu SH; Shen CC; Yi YC; Tsai JJ; Wang CC; Chueh JT; Lin KL; Lee TC; Pan HC; Sheu ML Br J Pharmacol; 2010 Aug; 160(8):1963-72. PubMed ID: 20649594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]